CHELSEA GARDNER: Open Payments
NPI 1265003826 · WALLINGFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 21 payments from 12 companies in 2025. Trend: 2023 $3,615 · 2024 $1,916 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 4 | $103 |
| Gilead Sciences, Inc. | 4 | $80 |
| Indivior Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Lundbeck LLC | 1 | $31 |
| ABBVIE INC. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $27 |
| Braeburn Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: APRETUDE, SUBLOCADE, REXULTI, VRAYLAR, Veozah, BRIXADI, Sunosi, BREZTRI.
Industry payments across CT — which companies pay providers there.
